VEGFA and neoplasm: Bagli et al. [15] have proved that luteolin inhibited tumor growth and angiogenesis in a murine xenograft model and decreased vascular endothelial growth factor (VEGF)-induced in vivo angiogenesis via inhibition of the phosphatidylinositol 3′-kinase (PI3K) pathway.